ID UBP37_PIG Reviewed; 982 AA. AC F1SRY5; DT 21-SEP-2011, integrated into UniProtKB/Swiss-Prot. DT 03-MAY-2011, sequence version 1. DT 27-MAR-2024, entry version 61. DE RecName: Full=Ubiquitin carboxyl-terminal hydrolase 37; DE EC=3.4.19.12 {ECO:0000250|UniProtKB:Q86T82}; DE AltName: Full=Deubiquitinating enzyme 37; DE AltName: Full=Ubiquitin thioesterase 37; DE AltName: Full=Ubiquitin-specific-processing protease 37; GN Name=USP37; OS Sus scrofa (Pig). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Laurasiatheria; Artiodactyla; Suina; Suidae; Sus. OX NCBI_TaxID=9823; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=Landrace; RG Swine Genome Sequencing Consortium.; RL Submitted (NOV-2009) to the EMBL/GenBank/DDBJ databases. CC -!- FUNCTION: Deubiquitinase that plays a role in different processes CC including cell cycle regulation, DNA replication or DNA damage CC response. Antagonizes the anaphase-promoting complex (APC/C) during CC G1/S transition by mediating deubiquitination of cyclin-A (CCNA1 and CC CCNA2), thereby promoting S phase entry. Specifically mediates CC deubiquitination of 'Lys-11'-linked polyubiquitin chains, a specific CC ubiquitin-linkage type mediated by the APC/C complex. Phosphorylation CC at Ser-628 during G1/S phase maximizes the deubiquitinase activity, CC leading to prevent degradation of cyclin-A (CCNA1 and CCNA2). Plays an CC important role in the regulation of DNA replication by stabilizing the CC licensing factor CDT1. Plays also an essential role beyond S-phase CC entry to promote the efficiency and fidelity of replication by CC deubiquitinating checkpoint kinase 1/CHK1, promoting its stability. CC Sustains the DNA damage response (DDR) by deubiquitinating and CC stabilizing the ATP-dependent DNA helicase BLM. Mechanistically, DNA CC double-strand breaks (DSB) promotes ATM-mediated phosphorylation of CC USP37 and enhances the binding between USP37 and BLM. Promotes cell CC migration by deubiquitinating and stabilizing the epithelial- CC mesenchymal transition (EMT)-inducing transcription factor SNAI. Plays CC a role in the regulation of mitotic spindle assembly and mitotic CC progression by associating with chromatin-associated WAPL and CC stabilizing it through deubiquitination. CC {ECO:0000250|UniProtKB:Q86T82}. CC -!- CATALYTIC ACTIVITY: CC Reaction=Thiol-dependent hydrolysis of ester, thioester, amide, peptide CC and isopeptide bonds formed by the C-terminal Gly of ubiquitin (a 76- CC residue protein attached to proteins as an intracellular targeting CC signal).; EC=3.4.19.12; Evidence={ECO:0000250|UniProtKB:Q86T82}; CC -!- SUBUNIT: Interacts with FZR1/CDH1. Interacts with CDT1. CC {ECO:0000250|UniProtKB:Q86T82}. CC -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q86T82}. CC Chromosome {ECO:0000250|UniProtKB:Q86T82}. CC -!- DOMAIN: The KEN box 3 is required for interaction with FZR1/CDH1 and is CC essential for APC(CDH1)-mediated ubiquitination. CC {ECO:0000250|UniProtKB:Q86T82}. CC -!- PTM: Polyubiquitinated via 'Lys-11'-linked ubiquitin by the APC(CDH1) CC complex during late mitosis, leading to its degradation. Able to CC mediate auto-deubiquitination. {ECO:0000250|UniProtKB:Q86T82}. CC -!- PTM: Phosphorylated at Ser-631 by CDK2 during G1/S phase but not during CC mitosis; phosphorylation at Ser-631 is required for deubiquitinase CC activity. Also polyubiquitinated during early G1 phase, without leading CC to degradation. Phosphorylated at Ser-115 by ATM following DNA damage, CC which in turn increases its deubiquitination activity towards BLM. CC {ECO:0000250|UniProtKB:Q86T82}. CC -!- SIMILARITY: Belongs to the peptidase C19 family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; CU570813; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR AlphaFoldDB; F1SRY5; -. DR SMR; F1SRY5; -. DR STRING; 9823.ENSSSCP00000017157; -. DR PaxDb; 9823-ENSSSCP00000017157; -. DR eggNOG; KOG1868; Eukaryota. DR InParanoid; F1SRY5; -. DR TreeFam; TF323032; -. DR Proteomes; UP000008227; Unplaced. DR Proteomes; UP000314985; Unplaced. DR Proteomes; UP000694570; Unplaced. DR Proteomes; UP000694571; Unplaced. DR Proteomes; UP000694720; Unplaced. DR Proteomes; UP000694722; Unplaced. DR Proteomes; UP000694723; Unplaced. DR Proteomes; UP000694724; Unplaced. DR Proteomes; UP000694725; Unplaced. DR Proteomes; UP000694726; Unplaced. DR Proteomes; UP000694727; Unplaced. DR Proteomes; UP000694728; Unplaced. DR GO; GO:0005694; C:chromosome; IEA:UniProtKB-SubCell. DR GO; GO:0005829; C:cytosol; IBA:GO_Central. DR GO; GO:0005634; C:nucleus; IBA:GO_Central. DR GO; GO:0004843; F:cysteine-type deubiquitinase activity; ISS:UniProtKB. DR GO; GO:0004197; F:cysteine-type endopeptidase activity; ISS:UniProtKB. DR GO; GO:0051301; P:cell division; IEA:UniProtKB-KW. DR GO; GO:0000082; P:G1/S transition of mitotic cell cycle; ISS:UniProtKB. DR GO; GO:0016579; P:protein deubiquitination; ISS:UniProtKB. DR GO; GO:0035871; P:protein K11-linked deubiquitination; ISS:UniProtKB. DR GO; GO:0071108; P:protein K48-linked deubiquitination; ISS:UniProtKB. DR GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW. DR GO; GO:0006275; P:regulation of DNA replication; ISS:UniProtKB. DR CDD; cd02257; Peptidase_C19; 2. DR CDD; cd13312; PH_USP37_like; 1. DR Gene3D; 3.90.70.10; Cysteine proteinases; 2. DR Gene3D; 2.30.29.180; Ubiquitin carboxyl-terminal hydrolase 26/29/37, pleckstrin homology-like domain; 1. DR InterPro; IPR038765; Papain-like_cys_pep_sf. DR InterPro; IPR001394; Peptidase_C19_UCH. DR InterPro; IPR003903; UIM_dom. DR InterPro; IPR032069; USP37-like_PH. DR InterPro; IPR038093; USP37-like_PH_sf. DR InterPro; IPR018200; USP_CS. DR InterPro; IPR028889; USP_dom. DR PANTHER; PTHR21646; UBIQUITIN CARBOXYL-TERMINAL HYDROLASE; 1. DR PANTHER; PTHR21646:SF23; UBIQUITIN CARBOXYL-TERMINAL HYDROLASE USP2; 1. DR Pfam; PF00443; UCH; 1. DR Pfam; PF16674; UCH_N; 1. DR Pfam; PF02809; UIM; 3. DR SMART; SM00726; UIM; 3. DR SUPFAM; SSF54001; Cysteine proteinases; 1. DR PROSITE; PS50330; UIM; 3. DR PROSITE; PS00972; USP_1; 1. DR PROSITE; PS00973; USP_2; 1. DR PROSITE; PS50235; USP_3; 1. PE 3: Inferred from homology; KW Cell cycle; Cell division; Chromosome; Hydrolase; Mitosis; Nucleus; KW Phosphoprotein; Protease; Reference proteome; Repeat; Thiol protease; KW Ubl conjugation; Ubl conjugation pathway. FT CHAIN 1..982 FT /note="Ubiquitin carboxyl-terminal hydrolase 37" FT /id="PRO_0000412646" FT DOMAIN 343..954 FT /note="USP" FT DOMAIN 707..726 FT /note="UIM 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00213" FT DOMAIN 809..828 FT /note="UIM 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00213" FT DOMAIN 831..850 FT /note="UIM 3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00213" FT REGION 128..162 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 183..307 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 672..705 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 720..798 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOTIF 32..34 FT /note="KEN box 1" FT /evidence="ECO:0000250" FT MOTIF 71..79 FT /note="D-box 1" FT /evidence="ECO:0000250" FT MOTIF 96..105 FT /note="D-box 2" FT /evidence="ECO:0000250" FT MOTIF 161..169 FT /note="D-box 3" FT /evidence="ECO:0000250" FT MOTIF 224..226 FT /note="KEN box 2" FT /evidence="ECO:0000250" FT MOTIF 785..787 FT /note="KEN box 3" FT /evidence="ECO:0000250" FT COMPBIAS 128..148 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 183..200 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 201..227 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 228..304 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 677..702 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 723..740 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 775..792 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT ACT_SITE 352 FT /note="Nucleophile" FT /evidence="ECO:0000250|UniProtKB:Q86T82, FT ECO:0000255|PROSITE-ProRule:PRU10092, ECO:0000255|PROSITE- FT ProRule:PRU10093" FT ACT_SITE 909 FT /note="Proton acceptor" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU10092, FT ECO:0000255|PROSITE-ProRule:PRU10093" FT MOD_RES 115 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q86T82" FT MOD_RES 171 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q86T82" FT MOD_RES 213 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q86T82" FT MOD_RES 631 FT /note="Phosphoserine; by CDK2" FT /evidence="ECO:0000250|UniProtKB:Q86T82" FT MOD_RES 653 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q86T82" FT MOD_RES 655 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q86T82" FT MOD_RES 773 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q86T82" SQ SEQUENCE 982 AA; 110483 MW; 3B09ABDE42E07AFF CRC64; MSPLKIQGPI RIRSMQTGIT KWKEGSFEIV EKENKVSLVV HYNTGGIPRI FQLSHNIKNV VLRPSGAKQS RLMLTLQDNS FLSIDKVPSK DAEEMRLFLD AVHQNRLNAV AMKPSQGSGS FGAILGSRTS QKETHRQLSY SDNQVSSKRG SLETKDDIPF RKVLGNPGRA SIKTAAGSGI TATRTIPSLT STSTPLRSGL LENRTEKRKR MLSSGSELNE DYPKENDSSS NNKAMTDPSR KYLTSSREKQ LSLKQSEENR TSGLLPLQSS SFYGSRAASK DYSPSSTNLD RTNISSQTPS AKRSLGFLPQ PAPLSVKKLR CNQDYTGWNK PRLPLSSHQQ QLQGFSNLGN TCYMNAILQS LFSLQSFAND LLKQGIPWKK IPLNALISRR FAHLLVKKDI CNSETKKDLL KKVKNAISAT AERFSGYMQN DAHEFLSQCL DQLKEDMEKL NKTWKTEPVP GEENSPDVTA TRVYTCPVIT NLEFEVQHSI ICKACGEIIP KREQFNDLSI DLPRRKKPLP PRSIQDSLDL FFRAEELEYS CEKCGGKCAL VRHKFNRLPR ILILHLKRYS FNVALSLNNK IGQQVIIPRY LTLSSHCTEN TKPPFNLGWS AQMAISRPLK ASQMVNSCIT SPSTPSKNFT FKSKSSLALS LDSDSEDELK RSVALSQRLC EISSSEQQQE DLEKDSKSCK LEPDKSELEN SGFDAMSEEE LLAAVLEISK REASPSPSHE DDDKPTSSPD TGFAEDDIQE MPENPDPMET EKPKTITEPD PASFTEITKD CDENKENKTP EGSQGEVDWL QQYDMERERE EQELQQALAQ SLQEQEAWEQ KEDDDLKRAT ELSLQEFNNS FLDSLGSDED SGNEDVLDME YTEAEAEELK RNAETGNLPH SYRLISVVSH IGSTSSSGHY ISDVYDIKKQ AWFTYNDLEV SKIQEASVQS DRDRSGYIFF YMHKEIFDEL LETEKNSQAL SMEVGKTTRQ AS //